Accelerated Pharma (Accelerated Pharma) Change In Inventory : $0.00 Mil (TTM As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Change In Inventory?

Accelerated Pharma's change in inventory for the quarter that ended in Mar. 2017 was $0.00 Mil. It means Accelerated Pharma's inventory stayed the same from Dec. 2016 to Mar. 2017 .

Accelerated Pharma's change in inventory for the fiscal year that ended in Dec. 2016 was $0.00 Mil. It means Accelerated Pharma's inventory stayed the same from Dec. 2015 to Dec. 2016 .

Accelerated Pharma's Total Inventories for the quarter that ended in Mar. 2017 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Accelerated Pharma Change In Inventory Historical Data

The historical data trend for Accelerated Pharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Change In Inventory Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Change In Inventory

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Change In Inventory	Get a 7-Day Free Trial			-	-	-	-	-

Accelerated Pharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Accelerated Pharma (NAS:ACCP) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Accelerated Pharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Accelerated Pharma's Inventory Turnover for the quarter that ended in Mar. 2017 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Accelerated Pharma's Inventory to Revenue for the quarter that ended in Mar. 2017 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

Accelerated Pharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines